Farhad Shahi, Mojtaba Gorji, A. P. o. P. O., Mehrdad Payandeh, A. P. o. H. &. O., Hamid Rezvani, A. P. o. H. &. O., Mohammad Vaezi, A. P. o. H. &. O., Sharareh Seifi, A. P. o. H. &. O., . . . Nassim Anjidani, P. D. (2022). Post-Marketing Surveillance of a generic Oxaliplatin (AlvoxalⓇ) in Iranian Patients with Cancer. Elsevier.
Chicago Style (17th ed.) CitationFarhad Shahi, et al. Post-Marketing Surveillance of a Generic Oxaliplatin (AlvoxalⓇ) in Iranian Patients with Cancer. Elsevier, 2022.
MLA (9th ed.) CitationFarhad Shahi, et al. Post-Marketing Surveillance of a Generic Oxaliplatin (AlvoxalⓇ) in Iranian Patients with Cancer. Elsevier, 2022.
Warning: These citations may not always be 100% accurate.